Glanbia upgrades full-year outlook on strong performances of dairy and health segments

The food and nutrition giant reported a 6% rise in revenues.

Irish food giant Glanbia upgraded its full-year guidance for 2025 on the back of strong results for the first half of the year, with revenues rising 6% to $1.93bn (€1.7bn) driven by growth in its Health & Nutrition (H&N) and Dairy Nutrition (DN) divisions.

The Kilkenny firm, which separated from the farmer-owned co-op Tirlán to focus on its global business, increased its interim dividend by 10% to 17.20 cent per share and returned €62.8m to shareholders via share buyback programs.

Glanbia's Health & Nutrition division, which creates flavourings and ingredients for other companies, saw an 18% revenue increase, driven by a 6.9% rise in volume and a significant 11.5% contribution from acquisition. Glanbia announced the acquisition of Sweetmix, a Brazil-based nutritional solutions business, to facilitate growth in the Latin American market.

The Dairy Nutrition segment delivered a 14.1% increase in revenue. This was driven by a combination of volume growth and favourable dairy market pricing.

Glanbia CEO Hugh McGuire.

However, the company's Performance Nutrition (PN) division faced challenges, with a 3.8% decline in revenue. This was primarily attributed to elevated whey protein costs and anticipated declines in non-core brands. 

However, Glanbia said there were positive signs of recovery, particularly with the flagship Optimum Nutrition brand, which saw a revenue increase in the second quarter. 

CEO Hugh McGuire said: “Today’s results reflect a first half of significant execution and progress as we generated 6% revenue growth in the period, underpinned by strong growth in H&N and DN and a sequential improvement in PN through the period as the Group navigated significant macroeconomic volatility.”

Glanbia announced the appointment of Paul Duffy as Chair-Designate, who will succeed Donard Gaynor on January 1.